Search results for "Cardiology"
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/22/1.htm
22 Nov 2016
USPSTF issues recommendations on statins for primary prevention
Among other recommendations, low- to moderate-dose statins should be started in adults 40 to 75 years of age who have no history of cardiovascular disease (CVD) but have at least 1 risk factor and a 10-year CVD event risk calculated at 10% or more.
https://immattersacp.org/weekly/archives/2016/11/15/1.htm
15 Nov 2016
Target preop visits for efficiency, best outcomes
Internists can guide preoperative anticoagulation, ensure that patients are in optimal condition for procedures, and##mdash;perhaps most importantly##mdash;judiciously choose which tests to perform and which ones aren't needed.
https://immattersacp.org/archives/2014/09/preop.htm
1 Sep 2014
Pearls for lowering lipids
New guidelines recommend basing treatment decisions on levels of risk rather than LDL targets.
https://immattersacp.org/archives/2016/07/lipids.htm
1 Jul 2016
ICDs may be underused among older patients after heart attack
Implantation may be overlooked during transitions of care, but an ICD was associated with lower 2-year mortality rates.
https://immattersacp.org/weekly/archives/2015/06/30/4.htm
30 Jun 2015
Fondaparinux associated with better outcomes than LMWH in NSTEMI study
Fondaparinux was associated with lower risk of major bleeding and death than low-molecular-weight heparin (LMWH) for patients with non-ST-segment elevation myocardial infarction (NSTEMI), a recent prospective study found.
https://immattersacp.org/weekly/archives/2015/02/24/6.htm
24 Feb 2015
Intensive blood pressure control in older patients associated with decreased cardiovascular events
Intensive blood pressure control led to a decreased rate of major adverse cardiovascular events, including cardiovascular death and heart failure, in older adults with hypertension, the study concluded.
https://immattersacp.org/weekly/archives/2017/01/31/1.htm
31 Jan 2017
ARBs may offer same efficacy, better tolerability than ACE inhibitors
Meta-regression analysis showed that the difference between angiotensin-converting enzyme (ACE) inhibitors and angiotensin-receptor blockers (ARBs) compared with placebo was due to a higher placebo event rate in the ACE inhibitor trials for the outcome of all-cause mortality, cardiovascular death, and myocardial infarction.
https://immattersacp.org/weekly/archives/2016/01/12/6.htm
12 Jan 2016
Trial of apixaban with single and combination antiplatelet therapy in ACS stopped early due to observed increase in major bleeding events
Full-dose anticoagulation, in combination with antiplatelet therapy of any kind in patients with acute coronary syndrome, results in substantial bleeding without any clear additional benefit and should only be considered when required for another condition.
https://immattersacp.org/weekly/archives/2015/08/11/4.htm
11 Aug 2015
MKSAP Quiz: Evaluation of risk for cardiovascular disease
A 49-year-old man is evaluated during a routine examination. He is asymptomatic but is concerned about his risk for cardiovascular disease. Medical history is notable for hypertension. He is a nonsmoker, and he works as an executive at a highly successful company. Family history is noncontributory. His only medication is hydrochlorothiazide. Following a physical exam and cholesterol and glucose testing, what is the most appropriate next step in management?
https://immattersacp.org/weekly/archives/2016/02/09/3.htm
9 Feb 2016